Yuri Agrawal
Concepts (318)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vestibular Diseases | 28 | 2025 | 45 | 9.570 |
Why?
| | Vestibule, Labyrinth | 18 | 2025 | 71 | 5.840 |
Why?
| | Postural Balance | 18 | 2026 | 241 | 4.480 |
Why?
| | Aging | 27 | 2025 | 1983 | 4.200 |
Why?
| | Accidental Falls | 18 | 2025 | 226 | 3.880 |
Why?
| | Reflex, Vestibulo-Ocular | 14 | 2022 | 29 | 3.860 |
Why?
| | Vertigo | 14 | 2024 | 40 | 3.660 |
Why?
| | Vestibular Evoked Myogenic Potentials | 14 | 2025 | 17 | 3.500 |
Why?
| | Alzheimer Disease | 9 | 2023 | 640 | 3.140 |
Why?
| | Vestibular Function Tests | 21 | 2025 | 35 | 3.040 |
Why?
| | Spatial Navigation | 5 | 2024 | 18 | 2.720 |
Why?
| | Cognitive Dysfunction | 8 | 2024 | 479 | 2.490 |
Why?
| | Hearing Loss | 11 | 2024 | 177 | 2.100 |
Why?
| | Saccule and Utricle | 6 | 2024 | 13 | 2.050 |
Why?
| | Semicircular Canals | 9 | 2020 | 31 | 1.990 |
Why?
| | Dizziness | 11 | 2023 | 93 | 1.940 |
Why?
| | Cross-Sectional Studies | 39 | 2025 | 5875 | 1.760 |
Why?
| | Longitudinal Studies | 27 | 2025 | 3005 | 1.700 |
Why?
| | Head Movements | 8 | 2022 | 38 | 1.540 |
Why?
| | Virtual Reality | 3 | 2024 | 82 | 1.460 |
Why?
| | Aged | 67 | 2026 | 26251 | 1.440 |
Why?
| | Vision Disorders | 7 | 2026 | 178 | 1.440 |
Why?
| | Aged, 80 and over | 35 | 2026 | 8351 | 1.440 |
Why?
| | Otologic Surgical Procedures | 8 | 2016 | 22 | 1.260 |
Why?
| | Physical Therapy Modalities | 3 | 2021 | 341 | 1.250 |
Why?
| | Gait | 5 | 2022 | 316 | 1.230 |
Why?
| | Baltimore | 11 | 2024 | 71 | 1.220 |
Why?
| | Head Impulse Test | 8 | 2019 | 9 | 1.210 |
Why?
| | Cognition Disorders | 3 | 2019 | 547 | 1.090 |
Why?
| | Eye Movements | 5 | 2015 | 91 | 1.020 |
Why?
| | Humans | 115 | 2026 | 145625 | 1.010 |
Why?
| | Ear, Inner | 2 | 2025 | 43 | 0.940 |
Why?
| | Neuroma, Acoustic | 5 | 2014 | 50 | 0.940 |
Why?
| | Male | 75 | 2026 | 73014 | 0.910 |
Why?
| | Sensorimotor Cortex | 1 | 2025 | 8 | 0.900 |
Why?
| | Female | 76 | 2026 | 79080 | 0.890 |
Why?
| | Middle Aged | 52 | 2025 | 36359 | 0.880 |
Why?
| | Independent Living | 4 | 2026 | 114 | 0.880 |
Why?
| | Entorhinal Cortex | 1 | 2025 | 15 | 0.870 |
Why?
| | Meniere Disease | 3 | 2014 | 12 | 0.830 |
Why?
| | Frontal Lobe | 1 | 2025 | 159 | 0.820 |
Why?
| | Health Surveys | 8 | 2018 | 511 | 0.800 |
Why?
| | Prevalence | 15 | 2022 | 2852 | 0.800 |
Why?
| | Telerehabilitation | 1 | 2024 | 49 | 0.780 |
Why?
| | Neurotology | 3 | 2018 | 5 | 0.740 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 338 | 0.700 |
Why?
| | Nutrition Surveys | 7 | 2021 | 270 | 0.690 |
Why?
| | Walking Speed | 2 | 2022 | 53 | 0.670 |
Why?
| | Orientation, Spatial | 1 | 2021 | 10 | 0.650 |
Why?
| | Adult | 43 | 2024 | 40821 | 0.650 |
Why?
| | Saccades | 3 | 2017 | 45 | 0.630 |
Why?
| | Healthy Aging | 1 | 2021 | 44 | 0.630 |
Why?
| | Sensation Disorders | 3 | 2026 | 37 | 0.620 |
Why?
| | Surveys and Questionnaires | 9 | 2023 | 6050 | 0.590 |
Why?
| | Proprioception | 1 | 2019 | 32 | 0.560 |
Why?
| | Space Perception | 2 | 2018 | 82 | 0.550 |
Why?
| | Bilateral Vestibulopathy | 1 | 2018 | 1 | 0.540 |
Why?
| | United States | 23 | 2026 | 16041 | 0.530 |
Why?
| | Bone Conduction | 3 | 2014 | 21 | 0.520 |
Why?
| | Otolithic Membrane | 2 | 2019 | 6 | 0.510 |
Why?
| | Accidents, Traffic | 1 | 2018 | 192 | 0.500 |
Why?
| | Developmental Disabilities | 1 | 2019 | 280 | 0.490 |
Why?
| | Activities of Daily Living | 3 | 2016 | 438 | 0.480 |
Why?
| | Social Participation | 1 | 2016 | 27 | 0.470 |
Why?
| | Risk Factors | 15 | 2026 | 10840 | 0.470 |
Why?
| | Frailty | 3 | 2025 | 206 | 0.470 |
Why?
| | Automobile Driving | 1 | 2018 | 156 | 0.450 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 421 | 0.440 |
Why?
| | Hearing | 3 | 2023 | 102 | 0.430 |
Why?
| | Psychotropic Drugs | 1 | 2015 | 75 | 0.420 |
Why?
| | Self Report | 2 | 2021 | 869 | 0.420 |
Why?
| | Referral and Consultation | 1 | 2021 | 878 | 0.420 |
Why?
| | Eye Movement Measurements | 1 | 2014 | 14 | 0.410 |
Why?
| | Hearing Loss, Noise-Induced | 2 | 2012 | 14 | 0.400 |
Why?
| | Reaction Time | 2 | 2015 | 434 | 0.400 |
Why?
| | Auditory Threshold | 3 | 2012 | 47 | 0.400 |
Why?
| | Walking | 5 | 2022 | 544 | 0.400 |
Why?
| | Prospective Studies | 9 | 2023 | 8087 | 0.390 |
Why?
| | Visual Perception | 1 | 2015 | 183 | 0.390 |
Why?
| | Turner Syndrome | 1 | 2014 | 61 | 0.380 |
Why?
| | Petrous Bone | 1 | 2012 | 7 | 0.380 |
Why?
| | Bone Cysts | 1 | 2012 | 12 | 0.380 |
Why?
| | Sleep Wake Disorders | 1 | 2017 | 314 | 0.370 |
Why?
| | Olfaction Disorders | 2 | 2023 | 74 | 0.360 |
Why?
| | Health Status Disparities | 1 | 2016 | 321 | 0.360 |
Why?
| | Hippocampus | 1 | 2018 | 986 | 0.360 |
Why?
| | Bone Density | 1 | 2016 | 492 | 0.360 |
Why?
| | Ear Canal | 1 | 2012 | 13 | 0.350 |
Why?
| | Tinnitus | 3 | 2022 | 22 | 0.350 |
Why?
| | Mouth Diseases | 2 | 2009 | 47 | 0.350 |
Why?
| | Point-of-Care Systems | 1 | 2014 | 185 | 0.350 |
Why?
| | Hypersensitivity | 1 | 2014 | 253 | 0.330 |
Why?
| | Dementia | 2 | 2026 | 322 | 0.330 |
Why?
| | Body Weight | 1 | 2015 | 964 | 0.320 |
Why?
| | Ear Neoplasms | 1 | 2010 | 9 | 0.320 |
Why?
| | Mobility Limitation | 3 | 2022 | 66 | 0.310 |
Why?
| | Cohort Studies | 9 | 2024 | 6045 | 0.310 |
Why?
| | Noise, Occupational | 1 | 2010 | 9 | 0.310 |
Why?
| | Electronic Health Records | 1 | 2018 | 1208 | 0.310 |
Why?
| | Odds Ratio | 5 | 2016 | 1070 | 0.300 |
Why?
| | Audiometry | 4 | 2012 | 34 | 0.300 |
Why?
| | Frail Elderly | 3 | 2025 | 136 | 0.300 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 567 | 0.300 |
Why?
| | Socioeconomic Factors | 4 | 2017 | 1323 | 0.290 |
Why?
| | Cardiovascular Diseases | 4 | 2015 | 2218 | 0.290 |
Why?
| | Diabetes Complications | 1 | 2010 | 219 | 0.290 |
Why?
| | Logistic Models | 5 | 2019 | 2112 | 0.280 |
Why?
| | Human papillomavirus 16 | 1 | 2008 | 27 | 0.280 |
Why?
| | Regression Analysis | 3 | 2017 | 994 | 0.270 |
Why?
| | Cognition | 4 | 2023 | 1286 | 0.270 |
Why?
| | Smell | 3 | 2023 | 129 | 0.270 |
Why?
| | Papillomavirus Infections | 2 | 2009 | 345 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 5 | 2025 | 3917 | 0.260 |
Why?
| | Severity of Illness Index | 2 | 2014 | 2910 | 0.250 |
Why?
| | Cytotoxins | 1 | 2006 | 15 | 0.240 |
Why?
| | Azathioprine | 1 | 2006 | 43 | 0.230 |
Why?
| | Multivariate Analysis | 5 | 2024 | 1531 | 0.230 |
Why?
| | Mental Disorders | 1 | 2015 | 1133 | 0.230 |
Why?
| | Laryngeal Diseases | 1 | 2006 | 31 | 0.230 |
Why?
| | Medicare | 2 | 2026 | 907 | 0.230 |
Why?
| | Rotation | 3 | 2015 | 122 | 0.220 |
Why?
| | Neuropsychological Tests | 3 | 2023 | 1136 | 0.220 |
Why?
| | Risk | 3 | 2015 | 917 | 0.220 |
Why?
| | Population Surveillance | 1 | 2008 | 477 | 0.220 |
Why?
| | Postoperative Period | 4 | 2016 | 344 | 0.210 |
Why?
| | Temporal Bone | 2 | 2016 | 43 | 0.210 |
Why?
| | Head and Neck Neoplasms | 2 | 2009 | 563 | 0.210 |
Why?
| | Incidence | 5 | 2026 | 2910 | 0.200 |
Why?
| | International Classification of Diseases | 1 | 2025 | 142 | 0.200 |
Why?
| | Sarcoidosis | 1 | 2006 | 164 | 0.200 |
Why?
| | Retrospective Studies | 11 | 2024 | 17291 | 0.200 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 627 | 0.200 |
Why?
| | Treatment Outcome | 9 | 2018 | 11744 | 0.190 |
Why?
| | Visual Acuity | 4 | 2021 | 497 | 0.190 |
Why?
| | Geriatric Assessment | 3 | 2025 | 238 | 0.190 |
Why?
| | Young Adult | 11 | 2024 | 14240 | 0.180 |
Why?
| | Adolescent | 10 | 2024 | 22451 | 0.180 |
Why?
| | Mastoiditis | 1 | 2022 | 10 | 0.180 |
Why?
| | Disability Evaluation | 2 | 2016 | 297 | 0.180 |
Why?
| | Bullying | 1 | 2023 | 42 | 0.180 |
Why?
| | Cerebellopontine Angle | 2 | 2012 | 6 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 67 | 0.180 |
Why?
| | White Matter | 1 | 2024 | 169 | 0.170 |
Why?
| | Neurodegenerative Diseases | 1 | 2024 | 147 | 0.170 |
Why?
| | Hearing Loss, Sudden | 1 | 2021 | 9 | 0.170 |
Why?
| | Reference Values | 2 | 2014 | 787 | 0.170 |
Why?
| | Immunosuppressive Agents | 1 | 2006 | 824 | 0.170 |
Why?
| | Motion Perception | 1 | 2021 | 20 | 0.160 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2021 | 81 | 0.160 |
Why?
| | Risk Assessment | 6 | 2018 | 3678 | 0.160 |
Why?
| | Ear Diseases | 2 | 2018 | 20 | 0.160 |
Why?
| | Crime Victims | 1 | 2023 | 131 | 0.160 |
Why?
| | Exercise Therapy | 1 | 2025 | 486 | 0.160 |
Why?
| | Anesthesiology | 1 | 2023 | 178 | 0.160 |
Why?
| | Migraine Disorders | 1 | 2022 | 109 | 0.150 |
Why?
| | Data Collection | 1 | 2023 | 647 | 0.150 |
Why?
| | Neurosurgical Procedures | 2 | 2012 | 207 | 0.150 |
Why?
| | Postoperative Complications | 4 | 2016 | 2962 | 0.150 |
Why?
| | Caloric Tests | 1 | 2019 | 2 | 0.140 |
Why?
| | Environmental Exposure | 2 | 2016 | 578 | 0.140 |
Why?
| | Age Factors | 3 | 2016 | 3321 | 0.140 |
Why?
| | Healthy Volunteers | 1 | 2019 | 217 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 266 | 0.130 |
Why?
| | Efficiency | 1 | 2018 | 102 | 0.130 |
Why?
| | Disease Susceptibility | 1 | 2019 | 339 | 0.130 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 880 | 0.120 |
Why?
| | Labyrinth Diseases | 1 | 2016 | 5 | 0.120 |
Why?
| | Otolaryngology | 1 | 2018 | 106 | 0.120 |
Why?
| | Eustachian Tube | 1 | 2016 | 9 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 2022 | 2766 | 0.120 |
Why?
| | Melanins | 1 | 2016 | 15 | 0.120 |
Why?
| | Audiometry, Pure-Tone | 2 | 2012 | 25 | 0.120 |
Why?
| | Pigmentation | 1 | 2016 | 50 | 0.120 |
Why?
| | Marital Status | 1 | 2016 | 47 | 0.110 |
Why?
| | Immunotherapy | 1 | 2020 | 669 | 0.110 |
Why?
| | Case-Control Studies | 3 | 2019 | 3633 | 0.110 |
Why?
| | Vestibular Nerve | 1 | 2015 | 6 | 0.110 |
Why?
| | Denervation | 1 | 2015 | 25 | 0.110 |
Why?
| | Linear Models | 1 | 2018 | 847 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 2018 | 286 | 0.110 |
Why?
| | Smoke | 1 | 2016 | 149 | 0.110 |
Why?
| | Confusion | 1 | 2015 | 30 | 0.110 |
Why?
| | Interviews as Topic | 2 | 2016 | 926 | 0.110 |
Why?
| | Brain | 2 | 2024 | 2981 | 0.110 |
Why?
| | Comorbidity | 1 | 2019 | 1652 | 0.110 |
Why?
| | Environment | 1 | 2016 | 295 | 0.110 |
Why?
| | Speech Perception | 2 | 2012 | 83 | 0.110 |
Why?
| | Hospital Rapid Response Team | 1 | 2014 | 20 | 0.100 |
Why?
| | Physicians | 1 | 2023 | 954 | 0.100 |
Why?
| | Melanoma | 1 | 2020 | 764 | 0.100 |
Why?
| | Nystagmus, Pathologic | 1 | 2014 | 16 | 0.100 |
Why?
| | Memory Disorders | 1 | 2015 | 197 | 0.100 |
Why?
| | Airway Management | 1 | 2014 | 84 | 0.100 |
Why?
| | Atrophy | 2 | 2024 | 199 | 0.100 |
Why?
| | Acoustic Stimulation | 1 | 2015 | 322 | 0.100 |
Why?
| | Locomotion | 1 | 2014 | 102 | 0.100 |
Why?
| | Ocular Motility Disorders | 1 | 2014 | 42 | 0.100 |
Why?
| | Sex Characteristics | 1 | 2019 | 798 | 0.100 |
Why?
| | Laryngoscopy | 1 | 2014 | 122 | 0.100 |
Why?
| | Sickness Impact Profile | 1 | 2013 | 67 | 0.100 |
Why?
| | Refractive Errors | 1 | 2013 | 36 | 0.100 |
Why?
| | Benign Paroxysmal Positional Vertigo | 1 | 2013 | 8 | 0.100 |
Why?
| | Mucocele | 1 | 2012 | 12 | 0.090 |
Why?
| | Encephalocele | 1 | 2012 | 13 | 0.090 |
Why?
| | Carcinoma, Adenoid Cystic | 1 | 2012 | 18 | 0.090 |
Why?
| | Antigens, Differentiation | 1 | 2012 | 75 | 0.090 |
Why?
| | Video Recording | 1 | 2014 | 218 | 0.090 |
Why?
| | Cranial Fossa, Middle | 1 | 2012 | 17 | 0.090 |
Why?
| | Quality Improvement | 2 | 2018 | 1325 | 0.090 |
Why?
| | Salivary Gland Neoplasms | 1 | 2012 | 39 | 0.090 |
Why?
| | Recurrence | 1 | 2016 | 1125 | 0.090 |
Why?
| | Smoking | 2 | 2010 | 1478 | 0.090 |
Why?
| | Vocal Cord Paralysis | 1 | 2012 | 27 | 0.090 |
Why?
| | Depressive Disorder | 1 | 2015 | 359 | 0.090 |
Why?
| | Anxiety Disorders | 1 | 2015 | 351 | 0.090 |
Why?
| | Age Distribution | 2 | 2013 | 395 | 0.090 |
Why?
| | Sex Distribution | 2 | 2013 | 379 | 0.090 |
Why?
| | Sex Factors | 2 | 2015 | 2101 | 0.090 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 328 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2026 | 1318 | 0.080 |
Why?
| | Motor Activity | 1 | 2016 | 701 | 0.080 |
Why?
| | Endolymphatic Hydrops | 1 | 2010 | 3 | 0.080 |
Why?
| | Functional Laterality | 1 | 2012 | 240 | 0.080 |
Why?
| | Respiratory Insufficiency | 1 | 2014 | 330 | 0.080 |
Why?
| | Educational Status | 1 | 2012 | 466 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3396 | 0.080 |
Why?
| | Microsurgery | 1 | 2010 | 74 | 0.080 |
Why?
| | Deglutition Disorders | 1 | 2011 | 159 | 0.080 |
Why?
| | Diabetic Neuropathies | 1 | 2010 | 100 | 0.070 |
Why?
| | Mental Health | 1 | 2016 | 771 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 443 | 0.070 |
Why?
| | Sleep | 1 | 2017 | 896 | 0.070 |
Why?
| | Exercise | 1 | 2021 | 2206 | 0.070 |
Why?
| | Craniotomy | 1 | 2009 | 83 | 0.070 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2009 | 56 | 0.070 |
Why?
| | Reoperation | 1 | 2012 | 633 | 0.070 |
Why?
| | Noise | 1 | 2009 | 67 | 0.070 |
Why?
| | Qualitative Research | 1 | 2016 | 1720 | 0.070 |
Why?
| | Diabetic Retinopathy | 1 | 2010 | 211 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1768 | 0.070 |
Why?
| | Patient Satisfaction | 1 | 2012 | 698 | 0.060 |
Why?
| | DNA Methylation | 1 | 2012 | 721 | 0.060 |
Why?
| | DNA, Viral | 1 | 2008 | 352 | 0.060 |
Why?
| | Radiosurgery | 1 | 2010 | 398 | 0.060 |
Why?
| | Occupational Exposure | 1 | 2010 | 356 | 0.060 |
Why?
| | Child | 3 | 2023 | 22638 | 0.060 |
Why?
| | Papillomavirus Vaccines | 1 | 2009 | 296 | 0.060 |
Why?
| | Sexual Behavior | 1 | 2009 | 489 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2097 | 0.050 |
Why?
| | Time Factors | 1 | 2016 | 7079 | 0.050 |
Why?
| | Health Services Accessibility | 2 | 2023 | 1101 | 0.050 |
Why?
| | Child, Preschool | 1 | 2019 | 11888 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1270 | 0.050 |
Why?
| | Pennsylvania | 1 | 2024 | 136 | 0.050 |
Why?
| | Quality of Life | 2 | 2013 | 3187 | 0.050 |
Why?
| | Firearms | 1 | 2010 | 434 | 0.050 |
Why?
| | Organ Size | 1 | 2024 | 463 | 0.050 |
Why?
| | Gray Matter | 1 | 2024 | 96 | 0.050 |
Why?
| | Cranial Sinuses | 1 | 2022 | 16 | 0.050 |
Why?
| | Career Mobility | 1 | 2023 | 68 | 0.050 |
Why?
| | Earache | 1 | 2022 | 6 | 0.050 |
Why?
| | Skull Base | 1 | 2022 | 53 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2022 | 238 | 0.040 |
Why?
| | Neck Pain | 1 | 2022 | 35 | 0.040 |
Why?
| | Maryland | 1 | 2021 | 67 | 0.040 |
Why?
| | Inflammation | 1 | 2012 | 2915 | 0.040 |
Why?
| | Motion | 1 | 2021 | 94 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2623 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1101 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1878 | 0.040 |
Why?
| | Telomere | 1 | 2023 | 300 | 0.040 |
Why?
| | Faculty, Medical | 1 | 2023 | 305 | 0.040 |
Why?
| | Schools | 1 | 2023 | 436 | 0.040 |
Why?
| | Acute Disease | 1 | 2022 | 1033 | 0.040 |
Why?
| | Vestibular Neuronitis | 1 | 2018 | 2 | 0.040 |
Why?
| | Movement | 1 | 2021 | 290 | 0.040 |
Why?
| | Syncope | 1 | 2018 | 48 | 0.030 |
Why?
| | Medical History Taking | 1 | 2018 | 116 | 0.030 |
Why?
| | Physical Examination | 1 | 2018 | 236 | 0.030 |
Why?
| | Neurology | 1 | 2018 | 107 | 0.030 |
Why?
| | Acoustic Impedance Tests | 1 | 2016 | 13 | 0.030 |
Why?
| | Cotinine | 1 | 2016 | 77 | 0.030 |
Why?
| | Pressure | 1 | 2016 | 221 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2857 | 0.030 |
Why?
| | Cadaver | 1 | 2016 | 302 | 0.030 |
Why?
| | Patient Safety | 1 | 2018 | 351 | 0.030 |
Why?
| | Acceleration | 1 | 2014 | 36 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1700 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1992 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1500 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 901 | 0.030 |
Why?
| | Hospitalization | 1 | 2024 | 2468 | 0.020 |
Why?
| | Salivary Glands | 1 | 2012 | 36 | 0.020 |
Why?
| | Cues | 1 | 2015 | 326 | 0.020 |
Why?
| | Surgical Instruments | 1 | 2012 | 51 | 0.020 |
Why?
| | CpG Islands | 1 | 2012 | 175 | 0.020 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2012 | 66 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2357 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2012 | 86 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1935 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2012 | 447 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 503 | 0.020 |
Why?
| | Software | 1 | 2016 | 673 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 868 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 365 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 693 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 840 | 0.020 |
Why?
| | Homosexuality | 1 | 2009 | 18 | 0.020 |
Why?
| | Heterosexuality | 1 | 2009 | 49 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1269 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2011 | 560 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1481 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2012 | 1429 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1293 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2012 | 2497 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5397 | 0.010 |
Why?
| | Prognosis | 1 | 2011 | 4331 | 0.010 |
Why?
| | Animals | 1 | 2019 | 38030 | 0.010 |
Why?
|
|
Agrawal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|